Posted by Michael Wonder on 24 May 2020
FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on COVID-19 vaccine project
22 May 2020 - FDA stalwart Janet Woodcock will temporarily step aside as the director of the agency’s Center for Drug Evaluation and Research to work solely on a White House initiative meant to accelerate COVID-19 treatments, Commissioner Stephen Hahn announced Friday in an agency-wide email.
The news is monumental for the FDA: Woodcock has served as the permanent director of CDER for more than a decade, since 2008.
